Targeted Therapy
Brand names:
Gleevec®
Other names:
Glivec, Imatinib Mesylate; STI-571
Often used for:
Imatinib is a type of medicine called a targeted therapy. This medicine is a tyrosine kinase inhibitor. It acts to block certain cell signals to help keep cells from growing. Imatinib is used to treat certain Philadelphia chromosome positive leukemias including Ph+ ALL and Ph+ CML.
Patients will have regular blood draws to check blood counts and monitor liver and kidney function.
May be taken as a tablet by mouth
Not all patients who take imatinib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Be sure to discuss these and other recommendations with your doctor or pharmacist.